Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Ophthalmology
|
| gptkbp:administered_by |
gptkb:cream
|
| gptkbp:approves |
gptkb:2003
gptkb:FDA |
| gptkbp:availability |
available in pharmacies
|
| gptkbp:available_in |
various concentrations
|
| gptkbp:brand |
gptkb:Zymaxid
|
| gptkbp:category |
gptkb:C
|
| gptkbp:class |
fluoroquinolone antibiotic
|
| gptkbp:clinical_trial |
conducted for efficacy
bacterial eye infections |
| gptkbp:clinical_use |
short-term treatment
|
| gptkbp:community_service |
safety not established in children
|
| gptkbp:contains |
gptkb:gatifloxacin
|
| gptkbp:contraindication |
hypersensitivity to gatifloxacin
|
| gptkbp:dosage_form |
sterile solution
1 drop in the affected eye(s) 3 times a day |
| gptkbp:duration_of_treatment |
up to 7 days
|
| gptkbp:financial_support |
available for financial assistance
|
| gptkbp:formulation |
sterile aqueous solution
|
| gptkbp:funding |
funded by pharmaceutical companies
|
| gptkbp:has_advisory_board |
reviewed by medical boards
|
| https://www.w3.org/2000/01/rdf-schema#label |
Zymaxid solution
|
| gptkbp:ingredients |
gptkb:gatifloxacin
|
| gptkbp:interacts_with |
may interact with other ophthalmic medications
|
| gptkbp:is_effective_against |
proven in clinical trials
|
| gptkbp:label |
must include usage instructions
|
| gptkbp:lactation |
consult doctor before use
|
| gptkbp:manufacturer |
gptkb:Allergan
|
| gptkbp:market |
monitored for safety issues
|
| gptkbp:marketed_as |
multiple countries
|
| gptkbp:mechanism_of_action |
inhibits bacterial DNA gyrase
|
| gptkbp:overdose_effects |
may cause increased side effects
|
| gptkbp:packaging |
gptkb:bottle
|
| gptkbp:patient_education |
instruct on proper administration
|
| gptkbp:patient_population |
consult healthcare provider before use
|
| gptkbp:pharmacokinetics |
rapidly absorbed in ocular tissues
|
| gptkbp:previous_name |
gatifloxacin ophthalmic solution
|
| gptkbp:price |
varies by pharmacy
|
| gptkbp:provides_guidance_on |
follow local guidelines for use
|
| gptkbp:replaces |
no specific withdrawal symptoms
|
| gptkbp:requires |
prescription only
|
| gptkbp:research |
ongoing for new formulations
|
| gptkbp:route_of_administration |
topical
|
| gptkbp:safety_features |
generally well tolerated
|
| gptkbp:shelf_life |
3 years
|
| gptkbp:side_effect |
allergic reactions
dry eyes eye irritation burning sensation |
| gptkbp:storage |
store at room temperature
|
| gptkbp:type_of_care |
important for treatment success
|
| gptkbp:used_for |
treatment of bacterial conjunctivitis
|
| gptkbp:bfsParent |
gptkb:Zymaxid
|
| gptkbp:bfsLayer |
7
|